Related Experiment Video
Updated: Apr 15, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
New steps forward in the neuroactive steroid field.
Silvia Giatti1, Luis Miguel Garcia-Segura2, Roberto Cosimo Melcangi1
1Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.
Systemic treatment with neuroactive steroids offers neuroprotection but presents complexities. Brain levels of neuroactive steroids (NS) don't always match plasma levels, impacting therapeutic outcomes.
Area of Science:
- Neuroendocrinology
- Neuropharmacology
- Steroid Biochemistry
Background:
- Neuroactive steroids (NS) show promise for neuroprotection via systemic treatment or modulating brain cell production.
- Recent evidence indicates a complex interplay between peripheral steroidogenesis and neural regulation of NS.
Purpose of the Study:
- To review current findings on neuroactive steroids, highlighting complexities in their therapeutic application.
- To explore the relationship between peripheral and central nervous system levels of NS.
Main Methods:
- Review of recent scientific literature and findings on neuroactive steroid synthesis, metabolism, and action.
- Analysis of studies investigating NS levels in plasma versus brain tissue under various conditions.
Main Results:
- Neural regulation of NS synthesis adapts to peripheral changes, but brain NS levels do not mirror plasma levels.
- In some cases, NS levels in the nervous system change in opposition to peripheral levels, suggesting potential for unexpected systemic treatment outcomes.
- Significant regional and sex-based differences exist in neural NS levels and signaling pathways.
Conclusions:
- The complex, regionally specific, and sex-dependent actions of NS necessitate careful consideration for therapeutic design.
- Understanding these complexities is crucial to avoid detrimental effects and harness the neuroprotective potential of NS.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Neurochemical Transmission: Sites of Drug Action
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

